Skip to main content
Retour
Watch Compare

REVELATION BIOSCIENCES, INC.

Qualité des données : 83%
Également cotée sous REVBW Nasdaq
REVB
Nasdaq Manufacturing Chemicals
1,23 €
▲ 0,02 € (1,65%)
Cap. Boursière: 4,58 M
Prix
1,23 €
Cap. Boursière
4,58 M
Fourchette du Jour
1,19 € — 1,28 €
Fourchette 52 Semaines
1,06 € — 44,16 €
Volume
62 481
Ouverture 1,22 €
Moyenne 50J / 200J
1,43 €
14,23% below
Moyenne 50J / 200J
5,50 €
77,62% below

Quick Summary

Points Clés

Negative free cash flow of -8,29 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-120,23%
En dessous de la moyenne du secteur (-53,47%)
ROIC-96,66%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio6,92
Interest CoverageN/A

Valorisation

PE (TTM)
-0,51
Au-dessus de la moyenne du secteur (-1,47)
P/B Ratio0,42
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,5 -1,5
P/B 0,4 1,6
ROE % -120,2 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -8,91 M
ROE -120,23% ROA -97,68%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -8,29 M
ROIC -96,66% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6,92
Interest Coverage N/A Asset Turnover N/A
Working Capital 10,98 M Tangible Book Value 11,00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,51 Forward P/E N/A
P/B Ratio 0,42 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -181,13%
Market Cap 4,58 M Enterprise Value -8,13 M
Per Share
EPS (Diluted TTM) -23,95 Revenue / Share N/A
FCF / Share -2,23 OCF / Share -2,22
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 92,99%
SBC-Adj. FCF -8,55 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -8,91 M -15,04 M -120 254,0 -10,83 M -2,13 M
EPS (Diluted) -23,95 -87,68 -0,53 -20,09 —
Gross Profit — — — — —
Operating Income -9,07 M -7,98 M -8,66 M -10,86 M —
EBITDA — — — — —
R&D Expenses 4,06 M 3,55 M 4,15 M 5,38 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — 41 759,0
Income Tax 0,0 0,0 0,0 0,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 11,58 M 6,62 M 12,21 M 5,50 M 48,39 M
Total Liabilities 2,72 M 1,91 M 5,56 M 4,45 M 8,40 M
Shareholders' Equity 8,86 M 4,71 M 6,65 M 1,05 M -7,82 M
Total Debt — — — — —
Cash & Equivalents 10,70 M 6,50 M 11,99 M 5,25 M 78 532,0
Current Assets 10,81 M 6,57 M 12,15 M 5,41 M 83 366,0
Current Liabilities 2,00 M 1,91 M 5,56 M 4,45 M 5,49 M